(Stock image generated with AI.)

Canada’s benchmark stock index climbed on Thursday, supported by stable gold prices and the high price of oil, as investors monitored developments in the Middle East and awaited a pivotal US-China summit.

President Donald Trump is expected to seek China’s assistance in resolving the unpopular conflict in Iran, as negotiations between Tehran and Washington remain at a standstill. Meanwhile, the Dow Jones Industrial Average reclaimed the 50,000 level during the session, boosted by strong earnings from Cisco Systems (NASDAQ:CSCO), which closed 13 per cent higher.

TSX34,268.27+226.84TSX
TSXV1,015.07-1.05TSXV
CSE176.07-2.82CSE
DJIA50,063.46+370.26DJIA
NASDAQ26,635.22+232.88NASDAQ
S&P 5007,501.24+56.99S&P 500

The Canadian dollar traded for 72.86 cents US compared to 72.97 cents US on Wednesday.

US crude futures traded $0.06 lower at US$101.00 a barrel, and the Brent contract lost $0.36 to US$105.30 a barrel.

The price of gold was down US$21.38 to US$4,676.88.

In world markets, the Nikkei was down 618.06 points to ¥62,654.05, the Hang Seng was up 0.60 of a point to HK$26,389.04, the FTSE was up 47.58 points to ₤10,372.93, and the DAX was up 315.81 points to €24,452.62.


More From The Market Online

Micro-cap AI company signs deal with top Latam fintech

NowVertical (TSXV:NOW) signed a three-year, US$4 million Google Cloud and AI solutions deal with a top Latin American fintech company.

Volatus Aerospace reports record Q1 margins as strategic expansion accelerates

Volatus Aerospace (TSX:FLT) reports stable revenue, strong profitability Q1 revenue steady at ~$5.6M, gross margin hit a record 35 per cent.

Bombardier expands FastTrack training program to address technician pipeline

Bombardier (TSX:BBD) introduced its FastTrack accelerated training program with WSU Tech and is expanding it to Hartford, Connecticut.

StockTalk | Cannabis Report: Quarterly reporting season is back

In a significant step forward for workplace safety and digital health diagnostics, biotech company MindBio Therapeutics (CSE:MBIO) has...